Magnetic Resonance Fingerprinting
MR Fingerprinting is currently in use for research at University Hospital Essen (Germany), and the Medical University of Vienna (Austria). Studies are being conducted in brain tumors and other neurological disorders, liver, heart and in the prostate.
Quantitative brain imaging
Case Study: MRF Imaging of the Brain
Siegfried Trattnig et al., Medical University Vienna, Austria
MRF has the potential to provide quantitative parameters, to help differentiate tumors in the brain.
Asymptomatic patient with Multiple Sclerosis.
Quantitative liver imaging
MRF is designed to acquire all information in a single scan and to provide:
- multiple quantitative maps
- perfect coregistration of different maps
- acquisition in a single breath-hold scan
This cannot be achieved by conventional methods that require multiple, separate scans.
Quantitative prostate imaging
Patient with prostate cancer in the left peripheral zone with reduced T1 and T2 values in MRF maps.
MRF case study of biopsy confirmed low grade prostate cancer
(Gleason score 3+3).
Quantitative cardiac imaging
Cardiac MRF compared to conventional mapping techniques: MRF has the potential to provide similar values to current quantitative methods.
Magnetic Resonance Fingerprinting is currently under development. It is not for sale in the U.S. and other countries. Its future availability cannot be guaranteed. As this is a research topic in predevelopment, all results shown are preliminary in nature and do not allow for generalizations or conclusions to be drawn. Product realization and features therein cannot be assured as the product may undergo futher design iterations.